Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 313 followers
Latest posts
Last updated about 17 hours ago
'Not here to refine the status quo': Excellergy emerges with $70M, plans to redefine allergy therapeutics
about 17 hours ago
The California biotech is developing a new drug class in hopes of...
Combining DNA, RNA testing helps identify blood cancer patients at increased risk of early relapse
about 18 hours ago
Researchers at The Institute of Cancer Research have found that a dual...
Tvardi's STAT3 inhibitor flunks phase 2 IPF trial amid high dropout rates
about 19 hours ago
Tvardi Therapeutics has failed its first big test as a public company...
Gilead, Arcus keep TIGIT dream alive with 27-month OS data from phase 2 cancer cohort
about 21 hours ago
Gilead and Arcus’ anti-TIGIT antibody domvanalimab has been tied to median overall...
Moderna posts melanoma data behind decision to say 'I do' to IDO
about 22 hours ago
Moderna has shared some of the phase 1/2 data that persuaded it...
Regeneron amplifies CHORD progression, sharing updated data on hearing loss gene therapy
1 day ago
Regeneron has posted updated clinical data on DB-OTO, providing more evidence of...
Neuroinflammation a Key Underlying Factor in Alzheimer’s Disease Risk
3 days ago
AAIC 2025 spotlights inflammation in Alzheimer’s; InMed’s INM-901 reduces key biomarkers linked...
Novo shutters cell therapy unit, ending work on potential Type 1 diabetes ‘cure’
4 days ago
Novo Nordisk is ending all work in cell therapy, including a Type...
How the shutdown impacts healthcare: Reductions in force begin at HHS
4 days ago
The federal government entered a shutdown Oct. 1 after Republicans and Democrats...
J&J in talks to buy immunology partner Protagonist: WSJ
4 days ago
Johnson & Johnson may be looking to deepen its relationship with immunology...
Fierce Biotech Fundraising Tracker '25: Arthrosi adds $153M; Expedition gears up with $165M
4 days ago
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million...
MIT first school to rebuff White House deal: ‘Scientific funding should be based on scientific merit alone’
4 days ago
The Massachusetts Institute of Technology (MIT) has refused the Trump administration’s deal...